The Human Genome Project: The Future of Medicine

Human Genome Project: The Future of Medicine Over the past half century, medicine has evolved rapidly, discovering treatments for many diseases, developing new surgical techniques, developing vaccines, and developing health and life expectancy of the general population Overall improvements were made. People often do not live in their 40s, but live over 75 years old. Medical research is exploring ways to make people more healthy and keep it that way. New cancer and AIDS research account for the majority of modern medicine.

The completion of the Human Genome Project in 2001 is definitely a breakthrough in the latest major biomedical sciences (CRISPR may be a competitor here, but it is a derivative of the Human Genome Project in many respects). The plan for this initiative began around 1984. Today, practical application of the Human Genome Project at the population level is just beginning to spread. To determine the human DNA sequence and use this information to improve the monotonous ocean between many humans. Life is huge

This big problem is promoting GP - write which is a follow - up to the human genome project. The leaders are expected to be able to deepen their understanding of biology by opening genes and writing new genomes and to lay the foundation for future technologies. They may synthesize the yeast genome by the end of the year. Jef Boeke of New York University, George Church of Harvard University, Andrew Hessel of Autodesk, and Nancy J Kelley, the founding director of the former New York Genome Center, are coordinated by the excellence center of Nonprofit Synthetic Biology. Several pilot projects are in progress, including attempts to make human cells (culture dishes) that can make all the vitamins and nutrients you need yourself. Some groups of GP writing focus on technical issues such as how to gather chromosomal length DNA strands.

In this harsh world, Shivom provides a platform for genomics platforms to advance genetic diseases and the future of precision medicine, a platform for individuals to access genomic sequences and store them in a secure distributed database. Following personal or third party personal agreement, this gives the pharmaceutical company the opportunity to specifically select the drug test subject. Individuals will have the opportunity to donate genomic information or obtain monetary rewards for genomic information.